» Articles » PMID: 15310660

Preference of DNA Methyltransferases for CpG Islands in Mouse Embryonic Stem Cells

Overview
Journal Genome Res
Specialty Genetics
Date 2004 Aug 18
PMID 15310660
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Many CpG islands have tissue-dependent and differentially methylated regions (T-DMRs) in normal cells and tissues. To elucidate how DNA methyltransferases (Dnmts) participate in methylation of the genomic components, we investigated the genome-wide DNA methylation pattern of the T-DMRs with Dnmt1-, Dnmt3a-, and/or Dnmt3b-deficient ES cells by restriction landmark genomic scanning (RLGS). Approximately 1300 spots were detected in wild-type ES cells. In Dnmt1(-/-) ES cells, additional 236 spots emerged, indicating that the corresponding loci are methylated by Dnmt1 in wild-type ES cells. Intriguingly, in Dnmt3a(-/-)Dnmt3b(-/-) ES cells, the same 236 spots also emerged, and no additional spots appeared differentially. Therefore, Dnmt1 and Dnmt3a/3b share targets in CpG islands. Cloning and virtual image RLGS revealed that 81% of the RLGS spots were associated with genes, and 62% of the loci were in CpG islands. By contrast to the previous reports that demethylation at repeated sequences was severe in Dnmt1(-/-) cells compared with Dnmt3a(-/-)Dnmt3b(-/-) cells, a complete loss of methylation was observed at RLGS loci in Dnmt3a(-/-)Dnmt3b(-/-) cells, whereas methylation levels only decreased to 16% to 48% in the Dnmt1(-/-) cells. We concluded that there are CpG islands with T-DMR as targets shared by Dnmt1 and Dnmt3a/3b and that each Dnmt has target preferences depending on the genomic components.

Citing Articles

Epigenetic regulation of matrix metalloproteinases in inflammatory diseases: a narrative review.

He J, Qin M, Chen Y, Hu Z, Xie F, Ye L Cell Biosci. 2020; 10:86.

PMID: 32695308 PMC: 7368751. DOI: 10.1186/s13578-020-00451-x.


The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.

Long M, Smiraglia D, Campbell M Biomolecules. 2017; 7(1).

PMID: 28216563 PMC: 5372727. DOI: 10.3390/biom7010015.


DNA methylation in hematopoietic development and disease.

Gore A, Weinstein B Exp Hematol. 2016; 44(9):783-790.

PMID: 27178734 PMC: 4992597. DOI: 10.1016/j.exphem.2016.04.013.


Epigenetics: A primer for clinicians.

Paluch B, Naqash A, Brumberger Z, Nemeth M, Griffiths E Blood Rev. 2016; 30(4):285-95.

PMID: 26969414 PMC: 5737767. DOI: 10.1016/j.blre.2016.02.002.


DNMT3A in haematological malignancies.

Yang L, Rau R, Goodell M Nat Rev Cancer. 2015; 15(3):152-65.

PMID: 25693834 PMC: 5814392. DOI: 10.1038/nrc3895.


References
1.
Lindsay S, Bird A . Use of restriction enzymes to detect potential gene sequences in mammalian DNA. Nature. 1987; 327(6120):336-8. DOI: 10.1038/327336a0. View

2.
Futscher B, Oshiro M, Wozniak R, Holtan N, Hanigan C, Duan H . Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet. 2002; 31(2):175-9. DOI: 10.1038/ng886. View

3.
Cooper D, Krawczak M . Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet. 1989; 83(2):181-8. DOI: 10.1007/BF00286715. View

4.
Li E, Bestor T, Jaenisch R . Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 1992; 69(6):915-26. DOI: 10.1016/0092-8674(92)90611-f. View

5.
Bestor T . Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. EMBO J. 1992; 11(7):2611-7. PMC: 556736. DOI: 10.1002/j.1460-2075.1992.tb05326.x. View